Green light to market the first post-partum antidepressant



[ad_1]

"This is the first license to treat this type of depression."
One of the most common side effects of this medication is a feeling of drowsiness and dryness of the mouth.
Sage Therapeutics has announced that the drug will be available in the US by the end of June. The treatment is supposed to cost $ 34,000, according to several American means.
A study by the Centers for Disease Control and Prevention (CDC) found that 11.5% of mothers had depression during delivery and after 2012 in the United States.

[ad_2]
Source link